Faculty of Medical Sciences

Staff Profile

Professor Craig Robson

Professor of Molecular Urology


Roles and Responsibilities

Head of Excellence in Learning and Teaching, Northern Institute for Cancer Research

Executive Board, Northern Institute for Cancer Research

Research Career Development Group, Faculty of Medical Sciences 



BSc (Hons) Sheffield University
PhD Newcastle University


Previous Positions

Research Fellow, ICRF, IMM,Oxford University 1988-1993
Lecturer, Surgery, Newcastle 1993-2000
Senior Lecturer, Surgical Sciences, Newcastle 2000-2002
Reader in Prostate Cancer, Northern Institute for Cancer Research, Newcastle University 2002-2005


Professional Body Membership

American Association for Cancer Research, British Association for Cancer Research, British Prostate Group, Society for Basic Urological Research, European Society for Urological Research, European Association of Urologists, European Association of Cancer Research


Committee Membership

Wales Cancer Bank Advisory Committee; BAUS Section of Academic Urology, Executive Committee; NCRI Biomarkers Advisory Group – Chair; Prostate Cancer UK Advisory Board


Editorial Board

Prostate Cancer; PLoS ONE, BJU International


Research Interests

I completed my PhD in Newcastle in 1987 before moving to the Weatherall Institute of Molecular Medicine, Oxford University as a Research Fellow to study DNA repair and drug resistance mechanisms in cancer.

I took up an academic appointment in urological research in the Department of Surgery at Newcastle University in 1993 and established a group of basic scientists and urologists with a strong translational research focus, primarily in prostate cancer. I have been actively involved in initiating and leading several National and European prostate cancer research networks.

A molecular and cell biologist by training, I study cell signalling in cancer. My current research focusses on understanding the molecular mechanisms that drive the progression to therapy-resistant, metastatic prostate cancer. A central theme of my research programme is the androgen receptor signalling cascade where my group has identified many critical epigenetic alterations that influence receptor function and created relevant cell models, including induced pluripotent stem cells.  I have a number of ongoing biotech collaborations that involve the identification and assay development of biomarkers that distinguish indolent from aggressive prostate cancer.



Medical Research Council, Prostate Cancer UK, Cancer Research UK, Tokai Pharmaceuticals, European Union, JGWP Foundation.



Head of Excellence in Learning and Teaching, Northern Institute for Cancer Research


Undergraduate Teaching

Module Leader BGM3024 - The Molecular Basis of Cancer

Module Leader BGM3065 – Biochemistry of Cancer and Chronic Diseases

Lecture on BMS3012 – Cancer Biology and Therapy

Lecture on BGM2002 - Biochemistry and Genetics of Signalling and the Cell Cycle


Postgraduate Teaching

On-line teaching module for MSc in Oncology and Palliative Care